Deep Tech Startups

Arcoris Bio develops multiplex biomarker detection technology for researchers and clinicians in biomedical research and diagnostics. The company's MUSE technology enables precise, sensitive detection of multiple biomarkers across fields including cancer, immunology, neuroscience, and pharmaceutical research.

2 investors

Arcos is a company focused on protecting critical infrastructure, operating in the security and defense technology market with an emphasis on strengthening Europe's technological sovereignty.

2 investors

Arcoscan develops biometric and AI-based age verification technology, built in collaboration with SRI International, that identifies a user's age through a face scan rather than physical IDs. Its technology targets age-restricted industries such as alcohol, tobacco, cannabis, online gambling, crypto, and gaming through mobile apps, point-of-sale, and embedded device integrations.

2 investors

Arctura develops advanced technologies including lightning protection systems, distributed nitric acid production, and optimization software for industrial applications.

2 investors

Arcturus develops advanced conductors by infusing carbon nanomaterials into metals to improve electrical conductivity and strength at high temperatures, aiming to scale the process to an industrial level. Its wires target electrification applications such as drones, robotics, EVs, electric planes, data centers, and transmission lines.

2 investors

Aren offers a patented software toolset that uses computer vision and machine learning to detect, quantify, and track damage on civil infrastructure assets such as bridges, producing 3D digital twins and predictive maintenance and capital allocation plans. It serves civil engineers and infrastructure asset owners to de-risk asset management, prioritize repairs, and optimize infrastructure spending.

2 investors

Arena Physica builds Atlas, an AI agent platform for hardware engineering that pairs general intelligence with deterministic physics models and integrations to design, simulation, and test tools. It helps engineering teams debug system failures, validate board designs, and optimize closed-loop hardware systems.

2 investors

ArgusEye builds autonomous AI engineers for product security in cyber-physical systems, operating inside R&D and engineering teams to model threats, prescribe security controls, and generate audit-ready evidence. The platform targets regulated industries including medical devices, consumer IoT, aerospace, robotics, industrial automation, and defense.

2 investors

Arnatar develops a next-generation RNA discovery platform called DARGER that combines gene silencing and gene upregulation technologies for oligonucleotide therapeutics. The platform serves pharmaceutical researchers and biotechnology companies developing treatments for genetic disorders and other disease areas.

2 investors

Arontier is a company that applies artificial intelligence to drug discovery, using proprietary technology and data to develop treatments for incurable and rare diseases. Founded in 2017, it collaborates with companies, experts, and scholars on new medicines and genetic editing.

2 investors

ArrePath is a biotechnology company that applies AI/ML to drug discovery and development. The company leverages computational platforms and data science to accelerate the identification and advancement of new therapeutic candidates across multiple disease areas.

2 investors

Arrowsmith Genetics is a preclinical-stage drug discovery company developing therapeutics from genetic research conducted at UBC and BC Cancer. The company was founded to advance potential treatments derived from 20+ years of scientific insights in cancer and genetic biology.

2 investors

Artica Therapeutics develops orally bioavailable small molecule inhibitors that use covalent chemistry to achieve antibody-like efficacy, positioned as an "antibody-in-a-pill" approach. The company targets severe autoimmune and inflammatory disorders for patients with immune-mediated conditions.

2 investors

Arx develops secure chips that embed blockchain authentication into physical items like apparel, collectibles, and certificates, enabling decentralized provenance verification and digital experiences without centralized servers.

2 investors

Aryballe operates an ISO 7 cleanroom manufacturing facility for sensor production, enabling chemical functionalization and testing at scale with up to 1 million sensors per year capacity. The in-house production line supports wafer-level processing on 8-inch substrates with integrated process optimization and industrial production.

2 investors

Ascendance develops hybrid-electric propulsion systems for next-generation aircraft and unmanned aerial vehicles, serving civil and defence operators seeking improved range, efficiency, and reduced environmental impact. The company's technology combines thermal and electric power to enable aircraft with significantly greater endurance and faster turnaround times than conventional alternatives.

2 investors

Ascension develops technology related to the extraction or supply of critical materials used in applications such as magnets for wind turbines, solar panel coatings, speakers, displays, and batteries. These materials support renewable energy and electronics manufacturing.

2 investors

Aspera builds uncrewed, long-range amphibious cargo aircraft designed to take off and land on both water and land, aiming to move freight by air at costs competitive with shipping. The company plans to mass-manufacture these cargo airplanes from India.

2 investors

Assemblr is a platform that allows users to create and share augmented reality content without requiring technical expertise. The platform serves creators and users across all experience levels who want to build AR experiences on a global scale.

2 investors

AST SpaceMobile is building a space-based cellular broadband network that connects directly to standard, unmodified smartphones via its BlueBird satellites, delivering 4G and 5G speeds. It partners with mobile network operators to extend coverage to underserved and unconnected areas for consumer, defense, maritime, aviation, and agricultural use.

2 investors

Aster develops autonomous research systems designed to accelerate scientific discovery by automating open-ended research tasks. The company aims to compress decades of research timelines into hours through AI-driven experimentation.

2 investors

Aston operates an integrated power service delivering utility-grade capacity through modular generation, transmission, storage, and real-time control systems. The company serves energy-intensive industrial users needing reliable, firm power without utility interconnection delays.

2 investors

Astonishing Labs partners with university lab scientists to commercialize early-stage biological research and build biotech platform companies aimed at developing new therapies. It focuses on funding research that departs from established scientific conventions, working at the earliest stage of the innovation life cycle.

2 investors

Astraveus develops the Lakhesys Benchtop Cell Factory, a microfluidic-based bioprocessing platform for scaling cell and gene therapy manufacturing with improved quality and cost efficiency. The company serves biotech and pharma organizations working on cell therapy manufacturing and commercialization.

2 investors